TELCON RF PHARMACEUTICAL. Inc.

A200230

KR7200230001

Communications & Networking

End-of-day quote Korea S.E. Other stock markets 23:00:00 01/07/2024 BST			5-day change	1st Jan Change
750 ^KRW	+3.02%		-2.47%	-14.09%

04-19	TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 22 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	CI
04-19	Abion Inc. announced that it has received KRW 19 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank	CI

V New Growth Bio Fund acquired 1.14% stake in Telcon Co., Ltd. from Telcon Holdings Co., Ltd. for KRW 4.3 billion.

August 25, 2016

V New Growth Bio Fund acquired 1.14% stake in Telcon Co., Ltd. (KOSDAQ:A200230) from Telcon Holdings Co., Ltd. for KRW 4.3 billion on August 25, 2016. V New Growth Bio Fund acquired 0.57 million shares at KRW 7,516.5 per share. V New Growth Bio Fund completed the acquisition of 1.14% stake in Telcon Co., Ltd. (KOSDAQ:A200230) from Telcon Holdings Co., Ltd. on August 25, 2016.

Latest news about TELCON RF PHARMACEUTICAL. Inc.

TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 22 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	04-18	CI
Abion Inc. announced that it has received KRW 19 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank	04-18	CI
TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 22 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd.	04-17	CI
Abion Inc. announced that it expects to receive KRW 19 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank	04-17	CI
Abion Inc. announced that it has received KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.	12-27	CI
TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 6 billion in funding from Abion Inc.	12-26	CI
TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 6 billion in funding from Abion Inc.	12-25	CI
Abion Inc. announced that it expects to receive KRW 7.999997049 billion in funding from TELCON RF PHARMACEUTICAL. Inc., Gencurix Inc.	12-19	CI
TELCON RF PHARMACEUTICAL. Inc.(KOSDAQ:A200230) dropped from S&P Global BMI Index	18/09/23	CI
TELCON RF PHARMACEUTICAL. Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	21/03/23	CI
TELCON RF PHARMACEUTICAL. Inc. Auditor Raises 'Going Concern' Doubt	20/03/23	CI
KPM TECH Co., Ltd. announced that it has received KRW 9.99999925 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	30/03/22	CI
KPM TECH Co., Ltd. announced that it expects to receive KRW 9.99999925 billion in funding from TELCON RF PHARMACEUTICAL. Inc.	22/03/22	CI
Humanigen’s Partner in South Korea Receives Ministry of Food and Drug Safety Approval to Conduct Phase 1 Study of Lenzilumab	22/07/21	CI
Humanigen, Inc Announces the Execution of Licensing Agreement with Telcon Rf Pharmaceutical, Inc. and KPM Tech Co., Ltd	03/11/20	CI
Telcon RF Pharmaceutical Inc. announced that it has received KRW 40.65 billion in funding from Hanil Vacuum Co., Ltd.	02/11/20	CI
Telcon RF Pharmaceutical Inc. acquired an additional 9.97% stake in KPM TECH Co., Ltd. from Evercore Investment Corp. for KRW 47.9 billion.	02/11/20	CI
Telcon RF Pharmaceutical Inc. announced that it has received KRW 30 billion in funding from Emmaus Life Sciences, Inc.	15/10/20	CI
TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 30 billion in funding from Emmaus Life Sciences, Inc.	27/09/20	CI
TELCON RF PHARMACEUTICAL. Inc. acquired an additional 3.73% stake in Abion Inc. from Leeds Investments Inc. and an individual for KRW 2.8 billion.	02/07/20	CI
TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 18 billion in funding from Hanil Vacuum Co., Ltd., Hanil Investment Co., Ltd.	03/06/20	CI
TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 10 billion in funding from Korea Securities Finance Corporation	30/05/19	CI
TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 10 billion in funding from Korea Securities Finance Corporation, and other investors	23/05/19	CI
Vivozon Inc. announced that it has received KRW 100 billion in funding from TELCON RF PHARMACEUTICAL. Inc., EstechPharma Co., Ltd.	24/05/18	CI
TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 7 billion in funding from KPM TECH Co., Ltd.	09/05/18	CI

Chart TELCON RF PHARMACEUTICAL. Inc.

Duration

Period

More charts

Company Profile

TELCON RF PHARMACEUTICAL. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Companyâs products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.

Sector

Communications & Networking

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Communications & Networking

	1st Jan change	Capi.
TELCON RF PHARMACEUTICAL. INC.	-14.09%	62.79M
CISCO SYSTEMS, INC.	-6.41%	190B
ARISTA NETWORKS, INC.	+51.59%	112B
FOXCONN INDUSTRIAL INTERNET CO., LTD.	+80.95%	74.74B
MOTOROLA SOLUTIONS, INC.	+23.53%	64.51B
GARMIN LTD.	+25.63%	31.02B
ZHONGJI INNOLIGHT CO., LTD.	+80.55%	21.99B
NOKIA OYJ	+18.48%	21.39B
ERICSSON	+4.90%	20.77B
ZTE CORPORATION	+4.72%	17.02B